Proceeds support clinical development for lead program in cholestatic and uremic pruritus and second program for mast cell-related...

Indigo Ag announces an additional $360M in financing, appoints Stéphane Bancel, Moderna CEO, to Board of Directors Indigo announces an...

Financing led by GV with participation from Matrix Capital Management, ARCH Venture Partners, Illumina Ventures, RTW Investments, Boxer...

SEATTLE — Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all...

Founders: David Perry, Geoffrey von Maltzahn and Noubar Afeyan CEO: David Perry Launched: 2014 Headquarters: Boston Funding: $850 million...

Cambridge-based Magenta Therapeutics announced today that it has entered a non-exclusive research and clinical collaboration agreement...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering,...

Multi-Target Collaboration Leverages Vividion's Screening Platform to Discover and Develop Highly Selective Small Molecules for E3...

Alpha-1 Antitrypsin Deficiency Program Demonstrates More than Four-Fold Increase in Circulating Levels of Functional Protein Following...